BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17124079)

  • 41. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early detection of cutaneous lymphoma.
    Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
    Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
    Whittaker S
    Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
    Kempf W; Dummer R; Burg G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cutaneous lymphoma: Kids are not just little people.
    Ferenczi K; Makkar HS
    Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
    Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
    J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous T-cell lymphoma: epidemiology, etiology, and classification.
    Willemze R
    Leuk Lymphoma; 2003; 44 Suppl 3():S49-54. PubMed ID: 15202525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous peripheral T-cell lymphomas, unspecified/NOS and rare subtypes: a heterogeneous group of challenging cutaneous lymphomas.
    Kempf W; Rozati S; Kerl K; French LE; Dummer R
    G Ital Dermatol Venereol; 2012 Dec; 147(6):553-62. PubMed ID: 23149701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous lymphomas: an update. Part 1: T-cell and natural killer/t-cell lymphomas and related conditions.
    Kempf W; Kazakov DV; Kerl K
    Am J Dermatopathol; 2014 Feb; 36(2):105-23. PubMed ID: 24556897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epitheliotropic lymphomas: better identification for improved treatment].
    Bagot M
    Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides/Sezary syndrome.
    Oschlies I; King RL; Dotlic S; Montes-Moreno S; Ponzoni M; Traverse-Glehen A; Calaminici M; Ferry JA; Ott G; Goodlad JR
    Virchows Arch; 2020 May; 476(5):683-699. PubMed ID: 31781845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [WHO classification and clinical spectrum of cutaneous lymphomas].
    Mitteldorf C; Grabbe S; Stadler R
    Hautarzt; 2017 Sep; 68(9):682-695. PubMed ID: 28831508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TCR-γ expression in primary cutaneous T-cell lymphomas.
    Rodríguez-Pinilla SM; Ortiz-Romero PL; Monsalvez V; Tomás IE; Almagro M; Sevilla A; Camacho G; Longo MI; Pulpillo Á; Diaz-Pérez JA; Montes-Moreno S; Castro Y; Echevarría B; Trébol I; Gonzalez C; Sánchez L; Otín AP; Requena L; Rodríguez-Peralto JL; Cerroni L; Piris MÁ
    Am J Surg Pathol; 2013 Mar; 37(3):375-84. PubMed ID: 23348211
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role.
    Ponti R; Bergallo M; Costa C; Quaglino P; Fierro MT; Comessatti A; Stroppiana E; Sidoti F; Merlino C; Novelli M; Alotto D; Cavallo R; Bernengo MG
    Br J Dermatol; 2008 Nov; 159(5):1131-7. PubMed ID: 18782321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prognosis of primary cutaneous lymphomas].
    Grange F; Bagot M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):30-40. PubMed ID: 11937927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous lymphomas-An update 2019.
    Kempf W; Zimmermann AK; Mitteldorf C
    Hematol Oncol; 2019 Jun; 37 Suppl 1():43-47. PubMed ID: 31187534
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.